Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1983 Jun;49(6):517–521. doi: 10.1136/hrt.49.6.517

Primary pulmonary hypertension.

S G Haworth
PMCID: PMC481343  PMID: 6342634

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blount S. G., Jr, Vogel J. H. Pulmonary hypertension. Mod Concepts Cardiovasc Dis. 1967 Nov;36(11):61–66. [PubMed] [Google Scholar]
  2. Bourdillon P. D., Oakley C. M. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. doi: 10.1136/hrt.38.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
  4. Camerini F., Alberti E., Klugmann S., Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J. 1980 Sep;44(3):352–356. doi: 10.1136/hrt.44.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DEXTER L. THROMBOEMBOLI AS A CAUSE OF COR PULMONALE. Bull N Y Acad Med. 1965 Sep;41:981–993. [PMC free article] [PubMed] [Google Scholar]
  6. Daoud F. S., Reeves J. T., Kelly D. B. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol. 1978 Nov;42(5):817–822. doi: 10.1016/0002-9149(78)90102-9. [DOI] [PubMed] [Google Scholar]
  7. Davies N. J., Denison D. M. The measurement of metabolic gas exchange and minute volume by mass spectrometry alone. Respir Physiol. 1979 Feb;36(2):261–267. doi: 10.1016/0034-5687(79)90029-x. [DOI] [PubMed] [Google Scholar]
  8. Ezekowitz M. D., Wilson D. A., Smith E. O., Burow R. D., Harrison L. H., Jr, Parker D. E., Elkins R. C., Peyton M., Taylor F. B. Comparison of Indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med. 1982 Jun 24;306(25):1509–1513. doi: 10.1056/NEJM198206243062502. [DOI] [PubMed] [Google Scholar]
  9. Fishman A. P. Primary pulmonary hypertension: more light or more tunnel? Ann Intern Med. 1981 Jun;94(6):815–817. doi: 10.7326/0003-4819-94-6-815. [DOI] [PubMed] [Google Scholar]
  10. Fujii A., Rabinovitch M., Matthews E. C. A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J. 1981 Nov;46(5):574–577. doi: 10.1136/hrt.46.5.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  12. GROVER R. F., VOGEL J. H., AVERILL K. H., BLOUNT S. G., Jr PULMONARY HYPERTENSION. INDIVIDUAL AND SPECIES VARIABILITY RELATIVE TO VASCULAR REACTIVITY. Am Heart J. 1963 Jul;66:1–3. doi: 10.1016/0002-8703(63)90062-0. [DOI] [PubMed] [Google Scholar]
  13. Gabella G. Structural changes in smooth muscle cells during isotonic contraction. Cell Tissue Res. 1976 Jul 26;170(2):187–201. doi: 10.1007/BF00224298. [DOI] [PubMed] [Google Scholar]
  14. Gould L., Chokshi A. B., Patel S., Gomes G. I. Hemodynamic evaluation of vasodilator drug therapy in primary pulmonary hypertension. Am Heart J. 1981 Aug;102(2):300–300. doi: 10.1016/s0002-8703(81)80025-7. [DOI] [PubMed] [Google Scholar]
  15. Gurtner H. P. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter? Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):897–923. [PubMed] [Google Scholar]
  16. Heath D., Smith P., Rios Dalenz J., Williams D., Harris P. Small pulmonary arteries in some natives of La Paz, Bolivia. Thorax. 1981 Aug;36(8):599–604. doi: 10.1136/thx.36.8.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heath D., Smith P. The electron microscopy of "fibrinoid necrosis" in pulmonary arteries. Thorax. 1978 Oct;33(5):579–595. doi: 10.1136/thx.33.5.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Honey M., Cotter L., Davies N., Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax. 1980 Apr;35(4):269–276. doi: 10.1136/thx.35.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hood W. B., Jr, Spencer H., Lass R. W., Daley R. Primary pulmonary hypertension: familial occurrence. Br Heart J. 1968 May;30(3):336–343. doi: 10.1136/hrt.30.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Huhta J. C., Smallhorn J. F., Macartney F. J. Two dimensional echocardiographic diagnosis of situs. Br Heart J. 1982 Aug;48(2):97–108. doi: 10.1136/hrt.48.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Inglesby T. V., Singer J. W., Gordon D. S. Abnormal fibrinolysis in familial pulmonary hypertension. Am J Med. 1973 Jul;55(1):5–14. doi: 10.1016/0002-9343(73)90144-7. [DOI] [PubMed] [Google Scholar]
  22. James T. N. Thrombi in antrum atrii dextri of human heart as clinically important source for chronic microembolisation to lungs. Br Heart J. 1983 Feb;49(2):122–132. doi: 10.1136/hrt.49.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kay J. M., Smith P., Heath D. Aminorex and the pulmonary circulation. Thorax. 1971 May;26(3):262–270. doi: 10.1136/thx.26.3.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mattocks A. R. Toxicity of pyrrolizidine alkaloids. Nature. 1968 Feb 24;217(5130):723–728. doi: 10.1038/217723a0. [DOI] [PubMed] [Google Scholar]
  25. Mlczoch J., Probst P., Szeless S., Kaindl F. Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake. Cor Vasa. 1980;22(4):251–257. [PubMed] [Google Scholar]
  26. Piper P., Vane J. The release of prostaglandins from lung and other tissues. Ann N Y Acad Sci. 1971 Apr 30;180:363–385. doi: 10.1111/j.1749-6632.1971.tb53205.x. [DOI] [PubMed] [Google Scholar]
  27. Robinson B. F., Collier J. G. Vascular smooth muscle. Correlations between basic properties and responses of human blood-vessels. Br Med Bull. 1979 Sep;35(3):305–312. doi: 10.1093/oxfordjournals.bmb.a071593. [DOI] [PubMed] [Google Scholar]
  28. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ross R., Klebanoff S. J. The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol. 1971 Jul;50(1):159–171. doi: 10.1083/jcb.50.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rubin L. J., Peter R. H. Primary pulmonary hypertension: new approaches to therapy. Am Heart J. 1980 Nov;100(5):757–759. doi: 10.1016/0002-8703(80)90246-x. [DOI] [PubMed] [Google Scholar]
  31. Ruskin J. N., Hutter A. M., Jr Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med. 1979 May;90(5):772–774. doi: 10.7326/0003-4819-90-5-772. [DOI] [PubMed] [Google Scholar]
  32. Schneider R. C., Zapol W. M., Carvalho A. C. Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis. 1980 Sep;122(3):445–451. doi: 10.1164/arrd.1980.122.3.445. [DOI] [PubMed] [Google Scholar]
  33. Smith P., Heath D., Kay J. M., Wright J. S., McKendrick C. S. Pulmonary arterial pressure and structure in the patas monkey after prolonged administration of aminorex fumarate. Cardiovasc Res. 1973 Jan;7(1):30–38. doi: 10.1093/cvr/7.1.30. [DOI] [PubMed] [Google Scholar]
  34. Thorens S., Haeusler G. Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol. 1979 Feb 15;54(1-2):79–91. doi: 10.1016/0014-2999(79)90410-2. [DOI] [PubMed] [Google Scholar]
  35. WINTERS W. L., Jr, JOSEPH R. R., LEARNER N. "PRIMARY" PULMONARY HYPERTENSION AND RAYNAUD'S PHENOMENON; CASE REPORT AND REVIEW OF THE LITERATURE. Arch Intern Med. 1964 Dec;114:821–830. doi: 10.1001/archinte.1964.03860120133017. [DOI] [PubMed] [Google Scholar]
  36. WOOD P. Pulmonary hypertension. Br Med Bull. 1952;8(4):348–353. doi: 10.1093/oxfordjournals.bmb.a074201. [DOI] [PubMed] [Google Scholar]
  37. Wagenvoort C. A. Hypertensive pulmonary vascular disease complicating congenital heart disease. A review. Cardiovasc Clin. 1973;5(1):43–60. [PubMed] [Google Scholar]
  38. Wagenvoort C. A. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest. 1980 May;77(5):614–625. doi: 10.1378/chest.77.5.614. [DOI] [PubMed] [Google Scholar]
  39. Wagenvoort C. A., Wagenvoort N. Hypoxic pulmonary vascular lesions in man at high altitude and in patients with chronic respiratory disease. Pathol Microbiol (Basel) 1973;39(3):276–282. doi: 10.1159/000162661. [DOI] [PubMed] [Google Scholar]
  40. Williams G. D., Westbrook K. C., Campbell G. S. Reflex pulmonary hypertension and systemic hypotension after microsphere pulmonary embolism: a myth. Am J Surg. 1969 Dec;118(6):925–930. doi: 10.1016/0002-9610(69)90259-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES